By Topic
Control Bionics (ASX: CBL) - This microcap's share price could explode higher from here!
The small-cap medical-tech company, Control Bionics, has just taken steps that could catapult it far beyond its current size. Its core product, a wearable sensor that translates even the faintest muscle or nerve signals into computer commands, is already approved and helps people with severe physical disabilities communicate and interact. Recently, the company announced that it had integrated a significant tech giant’s brain-computer interface protocol into its devices.
How Much Higher Can CETTIRE's (ASX: CTT) Share Price Go After the Recent Breakout?
Cettire (ASX: CTT) share price recently had a breakout. But it is in a bit of limbo; enough promise remains that a rebound could be on the cards, but enough uncertainty that it’s far from a safe bet. On one hand, the company is forecast to post healthy earnings-per-share growth over the next few years and has a pretty low price-to-sales ratio compared with peers, suggesting some latent value. On the other hand, consensus analyst targets hover modestly, some even see a drop, and many believe any upside beyond roughly one Australian dollar a share depends on improvements that aren’t guaranteed.
LaserBond (ASX: LBL)- Engineered for Investors Seeking Durable Industrial Growth Exposure
LaserBond (ASX: LBL) has entered a structurally stronger period after FY25 delivered clear evidence of operating leverage, improved manufacturing efficiencies, and accelerating adoption of its surface-engineered technologies across mining, energy, defence, and agricultural markets. With its patented LaserBond® cladding and composite coating systems now demonstrating superior lifecycle economics versus traditional wear-resistance methods, the company is positioned as a high-margin engineering solutions provider rather than a cyclical industrial.
CSL Limited (ASX: CSL) – Structural Quality Re-Asserted
We believe CSL Limited (ASX: CSL) remains one of the highest-quality global healthcare franchises listed on the ASX, with FY25 marking a clear re-acceleration in earnings quality, cash flow conversion, and strategic clarity. While the share price has periodically struggled to reflect this underlying strength, we view CSL as misunderstood rather than mis-executing.
3 ASX Stocks on Solid Share Price Uptrends
Every so often, the market serves up a handful of charts that practically nudge you to take a closer look. You know the type, steady higher lows, clean breakouts, and that subtle shift in momentum that hints at a story unfolding beneath the surface. In this piece, we’re turning the spotlight on three ASX-listed stocks whose price action has been speaking in a clear and confident tone. These aren’t wild speculative swings or one-off spikes; they’re structured uptrends that have earned their place on watchlists through consistent behaviour.
3 ASX stocks with confirmed bullish divergence patterns
The Australian share market has a habit of sending quiet signals before a move actually happens. One of the most reliable of those signals is bullish divergence, a moment when price looks weak, but momentum quietly starts to improve. In this article, we’ll take a closer look at three stocks listed on the (ASX) that are currently showing confirmed bullish divergence patterns.
...